BiOasis Financial Statements From 2010 to 2025
| BIOAF Stock | USD 0.0004 0.0003 300.00% |
Check BiOasis Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BiOasis Technologies' main balance sheet or income statement drivers, such as , as well as many indicators such as . BiOasis financial statements analysis is a perfect complement when working with BiOasis Technologies Valuation or Volatility modules.
BiOasis |
biOasis Technologies Company Shares Outstanding Analysis
BiOasis Technologies' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current BiOasis Technologies Shares Outstanding | 79.41 M |
Most of BiOasis Technologies' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, biOasis Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, biOasis Technologies has 79.41 M of shares currently outstending. This is 56.01% lower than that of the Biotechnology sector and 25.68% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 86.11% higher than that of the company.
biOasis Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BiOasis Technologies's current stock value. Our valuation model uses many indicators to compare BiOasis Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BiOasis Technologies competition to find correlations between indicators driving BiOasis Technologies's intrinsic value. More Info.biOasis Technologies is rated third in return on asset category among its peers. It is rated second in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BiOasis Technologies' earnings, one of the primary drivers of an investment's value.About BiOasis Technologies Financial Statements
BiOasis Technologies stakeholders use historical fundamental indicators, such as BiOasis Technologies' revenue or net income, to determine how well the company is positioned to perform in the future. Although BiOasis Technologies investors may analyze each financial statement separately, they are all interrelated. For example, changes in BiOasis Technologies' assets and liabilities are reflected in the revenues and expenses on BiOasis Technologies' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in biOasis Technologies. Please read more on our technical analysis and fundamental analysis pages.
Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut. Bioasis Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in BiOasis Pink Sheet
BiOasis Technologies financial ratios help investors to determine whether BiOasis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BiOasis with respect to the benefits of owning BiOasis Technologies security.